uzspbgmuУчёные записки Первого Санкт-Петербургского государственного медицинского университета имени академика И. П. ПавловаThe Scientific Notes of the Pavlov University1607-41812541-8807Academician I.P. Pavlov First St. Petersburg State Medical University10.24884/1607-4181-2020-27-4-14-27uzspbgmu-781Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESМикробиота и онкологические заболевания (обзор литературы)Microbiota and cancer (review of literature)https://orcid.org/0000-0003-3543-9884ВечерковскаяМ. Ф.VecherkovskayaM. F.

Вечерковская Мария Фёдоровна - кандидат медицинских наук, доцент кафедры микробиологии и вирусологии.

Санкт-Петербург.

3229-0798

Vecherkovskaya Maria F. - Cand. of Sci. (Med.), Associate Professor of the Department of Microbiology and Virology, Pavlov University.

Saint Petersburg.

mashavecher@yahoo.comhttps://orcid.org/0000-0003-3205-9018ТецГ. В.TetzG. V.

Тец Георгий Викторович - кандидат медицинских наук, ведущий научный сотрудник лаборатории иммунологии Научно-исследовательского центра.

Санкт-Петербург.

6952-3014

Tetz George V. - Cand. of Sci. (Med.), Leading Research Fellow of the Laboratory of Immunology of the Research Center, Pavlov University.

Saint Petersburg.

georgetets@gmail.comhttps://orcid.org/0000-0001-9047-6763ТецВ. В.TetzV. V.

Тец Виктор Вениаминович - доктор медицинских наук, академик РАЕН, профессор, зав. кафедрой микробиологии и вирусологии.

Санкт-Петербург.

4014-5771

Tetz Victor V. - Dr. of Sci. (Med.), Academician of the Russian Academy of Sciences, Professor, Head of the Department of Microbiology and Virology, Pavlov University.

Saint Petersburg.

vtetzv@yahoo.comПервый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова Министерства здравоохранения Российской ФедерацииРоссияPavlov UniversityRussian Federation2020261120202741427Copyright © Вечерковская М.Ф., Тец Г.В., Тец В.В., 20212021Вечерковская М.Ф., Тец Г.В., Тец В.В.Vecherkovskaya M.F., Tetz G.V., Tetz V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sci-notes.ru/jour/article/view/781

Представлены современные данные о вкладе микробиоты человека в развитие неопластических заболеваний, механизмы клеточной трансформации и эффективность химиотерапии. Описаны методы изучения микробиоты при опухолевых заболеваниях, перспективы создания неинвазивных методов диагностики неоплазий.

Article presents current data on the contribution of the human microbiota to the development of oncological conditions, microbial impact on cell transformation, influence on chemotherapy outcome. Brief description of the methods used for studying microbiota in carcinogenesis as well as prospects of creating non-invasive diagnostic tools is given.

микробиотаканцерогенезхимиотерапиядиагностикаmicrobiotacarcinogenesischemotherapydiagnosticsReferencesTetz G., Tetz V. Introducing the sporobiota and sporobiome. Gut Pathog // BioMed. Central. -2017. - Vol. 9, № 1. - P 1-6. Doi: 10.1186/s13099-017-0187-8.Tetz G., Tetz V. Introducing the sporobiota and sporo-biome // Gut Pathog. BioMed Central. 2017;9(1):1-6. Doi: 10.1186/s13099-017-0187-8.Ogilvie L. A, Jones B. V. The human gut virome. -a multifaceted majority // Front Microbiol. -2015. - Vol. 6, № 368. - P. 1753-1712. Doi: 10.3389/fmicb.2015.00918.Ogilvie L. A., Jones B. V. The human gut virome: a multifaceted majority. Front Microbiol. 2015 Sep 11; 6(e368):1753-1712. Doi: 10.3389/fmicb.2015.00918.Tetz G. V., Ruggles K. V., Zhou H. et al. Bacteriophages as potential new mammalian pathogens // Scientific Reports. Springer US. - 2017. - Vol. 7, № 1. - P. 1-9. Doi: 10.1038/s41598-017-07278-6.Tetz G. V., Ruggles K. V., Zhou H., Heguy A., Tsirigos A., Tetz V. Bacteriophages as potential new mammalian pathogens. Scientific Reports. Springer US. 2017;7(1):1-9. Doi: 10.1038/s41598-017-07278-6.Nash A. K., Auchtung T. A., Wong M. C. et al. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome // Microbiome. - 2017. - Vol. 5, № 1. - P. 1-13. Doi: 10.1186/s40168-017-0373-4.Nash A. K., Auchtung T. A., Wong M. C., Smith D. P., Gesell J. R., Ross M. C., Stewart C. J., Metcalf G. A., Muzny D. M., Gibbs R. A., Ajami N. J., Petrosino J. F. The gut mycobiome of the Human Microbiome Project healthy cohort // Microbiome. Microbiome. 2017;5(1):1-13. Doi: 10.1186/s40168-017-0373-4.Byrd A. L., Belkaid Y., Segre J. A. The human skin microbiome. Nature Publishing Group // Nature Publishing Group. - 2018. - Vol. 16, № 3. - P 143-155. Doi: 10.1038/nrmicro.2017.157.Byrd A. L., Belkaid Y., Segre J. A. The human skin microbiome. Nature Publishing Group. Nature Publishing Group; 2018;16(3):143-155. Doi: 10.1038/nrmicro.2017.157.Beck J. M., Young V. B. Research GHT. 2012. The microbiome of the lung // Elsevier. - 2012. - Vol. 160, № 4. -P. 258-266. Doi: 10.1016/j.trsl.2012.02.005.Beck J. M., Young V. B., Research G. H. T. The microbiome of the lung // Elsevier. 2012;160(4):258-66. Doi: 10.1016/j.trsl.2012.02.005.Francis P., Tangney M., Reid G. et al. Microbiota of Human Breast Tissue. - 2014. - Vol. 80, № 10. - P. 3007-3014. Doi: 10.1128/AEM.00242-14.Francis P., Tangney M., Reid G., Scott L., O'Hanlon D. M. Microbiota of Human Breast Tissue. 2014;80(10):3007-3014. Doi: 10.1128/AEM.00242-14.Castillo E., Meier R., Koestler D. C. et al. The Microbiomes of Pancreatic Tissue in Pancreatic Cancer and Non-Can-cer Subjects. bioRxiv // Cold Spring Harbor Laboratory. - 2017. - Vol. 44, № 5. - P. 189043. Doi: 10.1101/189043.del Castillo E., Meier R., Koestler D. C., Chen T., Paster B. J., Charpentier K. P., Kelsey K. T., Izard J., Michaud D. S. The Microbiomes of Pancreatic Tissue in Pancreatic Cancer and Non-Cancer Subjects. bioRxiv // Cold Spring Harbor Laboratory. 2017;44(5):189043. Doi: 10.1101/189043.Ecological dynamics of the vaginal microbiome in relation to health and disease. The American Journal of Obstetrics & Gynecology / S. Greenbaum, G. Greenbaum, J. Y. Moran-Gilad, A. Weintruab // Elsevier Inc. - 2019. - Vol. 220, № 4. - P. 1-12. Doi: 10.1016/j.ajog.2018.11.1089.Greenbaum S., Greenbaum G., Moran-Gilad J., Weintruab A. Ecological dynamics of the vaginal microbiome in relation to health and disease // The American Journal of Obstetrics & Gynecology. Elsevier Inc. 2019;220(4):1-12. Doi: 10.1016/j.ajog.2018.11.1089.Aagaard K., Ma J., Antony K. M. et al. The Placenta Harbors a Unique Microbiome // Sci. Transl. Med. - 2014. -Vol. 6, № 237. - P. 65-65. Doi: 10.1126/scitranslmed.3008599Aagaard K., Ma J., Antony K. M., Ganu R., Petrosino J., Versalovic J. The Placenta Harbors a Unique Microbiome // Sci Transl Med. 2014;6(237):65-75. Doi: 10.1126/scitranslmed.3008599.Aragon I. M., Herrera-Imbroda B. The urinary tract microbiome in health and disease // Elsevier. - 2018. - Vol. 4, № 1. - P. 128-138. Doi: 10.1016/j.euf.2016.11.001.Aragon I. M., Herrera-Imbroda B. The urinary tract microbiome in health and disease // Elsevier. 2018;4(1):128-38. Doi: 10.1016/j.euf.2016.11.001.Cani P. D. Human gut microbiome: hopes, threats and promises. Gut. BMJ Publishing Group. - 2018. - Vol. 67, № 9. - P. 1716-1725. Doi: 10.1136/gutjnl-2018-316723.Cani P. D. Human gut microbiome: hopes, threats and promises // Gut. BMJ Publishing Group. 2018;67(9):1716-1725. Doi: 10.1136/gutjnl-2018-316723.Miklossy J. Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch‘s and Hill's criteria. J Neuroinflammation // BioMed. Central. - 2011. -Vol. 8, № 1. - P. 1-16. Doi: 10.1186/1742-2094-8-90.Miklossy J. Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch‘s and Hill's criteria // J Neuroinflammation. BioMed Central. 2011;8(1):1-16. Doi: 10.1186/1742-2094-8-90.Emery D. C., Shoemark D. K., Batstone T. E. et al. 16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain // Front Aging Neurosci. - 2017. -Vol. 9. - P. 419-413. Doi: 10.3389/fnagi.2017.00195.Emery D. C., Shoemark D. K., Batstone T. E., Waterfall C. M., Coghill J. A., Cerajewska T. L., Davies M., West N. X., Allen S. J. 16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain // Front Aging Neurosci. 2017;(9):419-413. Doi: 10.3389/fnagi.2017.00195.Goodrich J. K., Di Rienzi S. C., Poole A. C. et al. Conducting a microbiome study // Cell. - 2014. - Vol. 158, № 2. - P. 250-262. Doi: 10.1016/j.cell.2014.06.037.Goodrich J. K., Di Rienzi S. C., Poole A. C., Koren O., Walters W. A., Caporaso J. G., Knight R., Ley R. E. Conducting a microbiome study // Cell. 2014;158(2):250-262. Doi: 10.1016/j.cell.2014.06.037.Weinstock G. M. Genomic approaches to studying the human microbiota // Nature. - 2012. -Vol. 489, № 7415. -P. 250-256. Doi: 10.1038/nature11553.Weinstock G. M. Genomic approaches to studying the human microbiota // Nature. 2012;489(7415):250-256. Doi: 10.1038/nature11553.Wang B., Yao M., Lv. L. et al. The Human Microbiota in Health and Disease. Engineering. Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company. - 2017. -Vol. 3, № 1. - P. 71-82. Doi: 10.1016/J.ENG.2017.01.008.Wang B., Yao M., Lv L., Ling Z., Li L. The Human Microbiota in Health and Disease // Engineering. Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company. 2017;3(1):71-82. Doi: 10.1016/J.ENG.2017.01.008.Stiemsma L. T, Michels K. B. The Role of the Microbiome in the Developmental Origins of Health and Disease. Pediatrics. - 2018. -Vol. 141, № 4. - P. e20172437-24. Doi: 10.1542/peds.2017-2437.Stiemsma L. T., Michels K. B. The Role of the Microbiome in the Developmental Origins of Health and Disease // Pediatrics. 2018;141(4):e20172437-24. Doi: 10.1542/peds.2017-2437.Honda K., Littman D. R. The microbiota in adaptive immune homeostasis and disease // Nature. - 2016. - Vol. 535, № 7610. -P. 75-84. Doi: 10.1038/nature18848.Honda K., Littman D. R. The microbiota in adaptive immune homeostasis and disease // Nature. 2016;535(7610):75-84. Doi: 10.1038/nature18848.Gilbert J. A., Quinn R. A., Debelius J. Microbiome-wide association studies link dynamic microbial consortia to disease // Nature. - 2016 . - Vol. 535, № 7610. -P. 94-103. Doi: 10.1038/nature18850.Gilbert J. A., Quinn R. A., Debelius J., Xu Z. Z., Morton J,. Garg N., Jansson J. K., Dorrestein P. C., Knight R. Microbiome-wide association studies link dynamic microbial consortia to disease // Nature. 2016;535(7610):94-103. Doi: 10.1038/nature18850.Kho Z.Y., Lal S. K. The Human Gut Microbiome -A Potential Controller of Wellness and Disease // Front Microbiol. - 2018. - Vol. 14, № 9. - P. 215-223. Doi: 10.3389/fmicb.2018.01835.Kho Z. Y., Lal S. K. The Human Gut Microbiome - A Potential Controller of Wellness and Disease. Front Microbiol. 2018;(9):215-223. Doi: 10.3389/fmicb.2018.01835.Morgan X. C., Huttenhower C. Chapter 12. Human microbiome analysis / eds by F. Lewitter, M. Kann // PLoS Comput Biol // Public Library of Science. - 2012. - Vol. 8, № 12. - P. e1002808. Doi: 10.1371/journal.pcbi.1002808.Morgan X. C., Huttenhower C. Chapter 12. Human microbiome analysis / eds by F. Lewitter, M. Kann // PLoS Comput Biol. Public Library of Science; 2012;8(12):e1002808. Doi: 10.1371/journal.pcbi.1002808.Goodrich J. K., Waters J. L., Poole A. C. Human Genetics Shape the Gut Microbiome // Cell. Cell Press. - 2014. -Vol. 159, № 4. - P. 789-799. Doi: 10.1016/j.cell.2014.09.053.Goodrich J. K., Waters J. L., Poole A. C., Sutter J. L., Koren O., Blekhman R., Beaumont M., Van Treuren W., Knight R., Bell J. T., Spector T. D., Clark A. G., Ley R. E. Human Genetics Shape the Gut Microbiome // Cell. Cell Press. 2014;159(4):789-799. Doi: 10.1016/j.cell.2014.09.053.Wang J., Thingholm L. B, Skieceviciene J. et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota // Nat Genet. - 2016. - Vol. 48, № 11. - P. 1396-1406. Doi: 10.1038/ng.3695.Wang J., Thingholm L. B., Skieceviciene J., Rausch P., Kummen M., Hov J. R., Degenhardt F., Heinsen F. A., Ruhlemann M. C., Szymczak S., Holm K., Esko T., Sun J, Pricop-Jeckstadt M, Al-Dury S., Bohov P., Bethune J., Sommer F., Ellinghaus D., Berge R. K., Hubenthal M., Koch M., Schwarz K., Rimbach G., Hubbe P., Pan W.-H., Sheibani-Tezerji R,. Hasler R,. Rosenstiel P., D'Amato M., Cloppenborg-Schmidt K., Kunzel S., Laudes M., Marschall H.-U., Lieb W., Nothlings U., Karlsen T. H., Baines J. F., Franke A. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota // Nat Genet. 2016;48(11):1396-1406. Doi: 10.1038/ng.3695.Benson A. K. The gut microbiome-an emerging complex trait. Nature Publishing Group. Nature Publishing Group. - 2016. - Vol. 48, № 11. - P. 1301-1302. Doi: 10.1038/ng.3707.Benson A. K. The gut microbiome-an emerging complex trait // Nature. Nature Publishing Group. 2016; 48(11):1301-1302. Doi: 10.1038/ng.3707.Sonnenburg E. D., Smits S. A., Tikhonov M. et al. Diet-induced extinctions in the gut microbiota compound over generations // Nature. Nature Publishing Group. - 2016. -Vol. 529, № 7585. - P. 212-215. Doi: 10.1038/nature16504.Sonnenburg E. D., Smits S. A., Tikhonov M., Higginbottom S. K., Wingreen N. S., Sonnenburg J. L. Diet-induced extinctions in the gut microbiota compound over generations // Nature. Nature Publishing Group. 2016;529(7585):212-215. Doi: 10.1038/nature16504.Substantial contribution of extrinsic risk factors to cancer development / S. Powers, W. Zhu, S. Wu, Y. A Hannun // Nature. Nature Publishing Group. - 2015. - Vol. 529, № 7584. - P. 1-15. Doi: 10.1038/nature16166.Powers S., Zhu W., Wu S., Hannun Y. A. Substantial contribution of extrinsic risk factors to cancer development // Nature. Nature Publishing Group. 2015;529(7584):1-15. Doi: 10.1038/nature16166.IARC Working Group on the Evaluation of Carcinogenic Risks to Humans // Biological agents. Volume 100 B: A review of human carcinogens. IARC monographs on the evaluation of carcinogenic risks to humans. - 2012. - Vol. 100. - P. 1-441. PMID: 23189750. PMCID: PMC4781184.IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. Vol. 100, IARC monographs on the evaluation of carcinogenic risks to humans. 2012; (100):1-441. PMID: 23189750; PMCID: PMC4781184.Liu W., MacDonald M. Merkel cell polyomavirus infection and Merkel cell carcinoma // Elsevier. - 2016. -Vol. 20. - P. 20-7. Doi: 10.1016/j.coviro.2016.07.011.Liu W., MacDonald M. Merkel cell polyomavirus infection and Merkel cell carcinoma // Elsevier. 2016;(20):20-27. Doi: 10.1016/j.coviro.2016.07.011.Scanu T., Spaapen R. M., Bakker J. M. et al. Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma // Cell. Host. and Microbe. - 2015. - Vol. 17, № 6. - P. 763-774. Doi: 10.1016/j.chom.2015.05.002.Scanu T., Spaapen R. M., Bakker J. M., Pratap C. B., Wu L.-E., Hofland I., Broeks A., Shukla V. K., Kumar M., Janssen H., Song J.-Y., Neefjes-Borst E. A., Riele te H., Holden D. W., Nath G., Neefjes J. Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma // Cell Host and Microbe. 2015;17(6):763-774. Doi: 10.1016/j.chom.2015.05.002.Mughini-Gras L., Schaapveld M., Kramers J. et al. Increased colon cancer risk after severe Salmonella infection. Schildgen O, editor. PLoS ONE // Public Library of Science. - 2018. - Vol. 13, № 1. - P. e0189721. Doi: 10.1371/journal.pone.0189721.Mughini-Gras L., Schaapveld M., Kramers J., Mooij S., Neefjes-Borst E. A., Pelt W. V., Neefjes J. Increased colon cancer risk after severe Salmonella infection // PLoS ONE. Public Library of Science. 2018;13(1):e0189721. Doi: 10.1371/journal.pone.0189721.Trabert B., Waterboer T. Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations // JNCI J Natl Cancer Inst. - 2019. - Vol. 111, № 2. Doi: 10.1093/jnci/djy084.Trabert B., Waterboer T. Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations // JNCI J Natl Cancer Inst. 2019;111(2): djy084 Doi: 10.1093/jnci/djy084.Kostic A. D., Chun E., Robertson L. et al. Fusobac-terium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment // Cell Host and Microbe. Cell Press. - 2013. - Vol. 14, № 2. - P. 207-215. Doi: 10.1016/j.chom.2013.07.007.Kostic A. D., Chun E., Robertson L., Glickman J. N., Gallini C. A., Michaud M., Clancy T. E., Chung D. C., Lochhead P., Hold G. L., El-Omar E. M., Brenner D., Fuchs C. S., Meyerson M., Garrett W. S. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment // Cell Host and Microbe. Cell Press. 2013;14(2):207-215. Doi: 10.1016/j.chom.2013.07.007.Buc E., Dubois D., Sauvanet P. et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer / eds by J. R. Battista// PLoS ONE. Public Library of Science. - 2013. - Vol. 8, № 2. - P.e56964. Doi: 10.1371/journal.pone.0056964.Buc E., Dubois D., Sauvanet P., Raisch J., Delmas J., Darfeuille-Michaud A., Pezet D., Bonnet R. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer // PLoS ONE. Public Library of Science. 2013;8(2):e56964. Doi: 10.1371/journal.pone.0056964.Toprak N. U., Yagci A., Gulluoglu B. M. et al. Possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer // Clin. Microbiol. Infect. - 2006. - Vol. 12, № 8. - P. 782-786. Doi: 10.1111/j.1469-0691.2006.01494.x.Toprak N. U., Yagci A., Gulluoglu B. M., Akin M. L., Demirkalem P., Celenk T., Soyletir G. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer // Clin Microbiol Infect. 2006;12(8):782-786. Doi: 10.1111/j.1469-0691.2006.01494.x.Cohen R. J., Shannon B. A. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution // The Journal Of Urology. - 2005. - Vol. 173. - P. 1969-1974. Doi: 10.1097/01.ju.0000158161.15277.78.Cohen R. J., Shannon B. A. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? // The Journal Of Urology. 2005:1969-1974. Doi: 10.1097/01.ju.0000158161.15277.78.Shinohara D. B., Vaghasia A. M., Yu S.-H. et al. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate. - 2013. - Vol. 73, № 9. - P.1007-1015. Doi: 10.1002/pros.22648.Shinohara D. B., Vaghasia A. M., Yu S.-H., Mak T. N., Bruggemann H., Nelson W. G., De Marzo A. M., Yegnasubramanian S., Sfanos K. S. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate. 2013;73(9):1007-1015. Doi: 10.1002/pros.22648.Banerjee S., Alwine J. C., Wei Z. et al. Microbiome signatures in prostate cancer // Carcinogenesis. - 2019. -Vol. 349. - P. 7-16. Doi: 10.1093/carcin/bgz008.Banerjee S., Alwine J. C., Wei Z., Tian T., Shih N., Sperling C., Guzzo T., Feldman M. D., Robertson E. S. Microbiome signatures in prostate cancer Carcinogenesis. 2019; 349:7-16. Doi: 10.1093/carcin/bgz008.Shrestha E., White J. R., Yu S.-H. et al. Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer // Journal of Urology. - 2018. - Vol. 199, № 1. - P. 161-171. Doi: 10.1016/j.juro.2017.08.001.Shrestha E., White J. R., Yu S.-H., Kulac I., Ertunc O., De Marzo A. M., Yegnasubramanian S., Mangold L. A., Partin A. W., Sfanos K. S. Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer // Journal of Urology. 2018;199(1):161-71. Doi: 10.1016/j.juro.2017.08.001.Geller L. T., Barzily-Rokni M., Danino T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine // Science. - 2017. - Vol. 357, № 6356. - P. 1156-1160. Doi: 10.1126/science.aah5043.Geller L. T., Barzily-Rokni M., Danino T., Jonas O. H., Shental N., Nejman D., Gavert N., Zwang Y., Cooper Z. A., Shee K., Thaiss C. A., Reuben A., Livny J., Avraham R., Frederick D. T., Ligorio M., Chatman K., Johnston S. E., Mosher C. M., Brandis A., Fuks G., Gurbatri C., Gopalakrishnan V., Kim M., Hurd M. W., Katz M., Fleming J., Maitra A., Smith D. A., Skalak M., Bu J., Michaud M., Trauger S. A., Barshack I., Golan T., Sandbank J., Flaherty K. T., Mandinova A., Garrett W. S., Thayer S. P , Ferrone C. R., Huttenhower C., Bhatia S. N., Gevers D., Wargo J. A., Golub T. R., Straussman R. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine // Science. 2017;357(6356):1156-1160. Doi: 10.1126/science.aah5043.Urbaniak C., Gloor G. B., Brackstone M. et al. The Microbiota of Breast Tissue and Its Association with Breast Cancer / eds by H. Goodrich-Blair // Applied microbiology / American Society for Microbiology. - 2016. - Vol. 82, № 16. - P. 5039-5048. Doi: 10.1128/AEM.01235-16.Urbaniak C., Gloor G. B., Brackstone M., Scott L., Tangney M., Reid G., Goodrich-Blair H. The Microbiota of Breast Tissue and Its Association with Breast Cancer // Applied microbiology. American Society for Microbiology. 2016;82(16):5039-5048. Doi: 10.1128/AEM.01235-16.Xuan C., Shamonki J. M., Chung A. et al. Microbial dysbiosis is associated with human breast cancer. Takabe K, editor. PLoS ONE // Public Library of Science. - 2014. -Vol. 9, № 1. - P. e83744. Doi: 10.1371/journal.pone.0083744.Xuan C., Shamonki J. M., Chung A., Dinome M. L., Chung M, Sieling P. A., Lee D. J. Microbial dysbiosis is associated with human breast cancer // PLoS ONE. Public Library of Science. 2014;9(1):e83744. Doi: 10.1371/journal.pone.0083744.Hieken T. J., Chen J., Hoskin T. L. et al. The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease. Scientific Reports // Nature Publishing Group. - 2016. - Vol. 6, № 1. - P. 30751. Doi: 10.1038/srep30751.Hieken T. J., Chen J., Hoskin T. L., Walther-Antonio M., Johnson S., Ramaker S., Xiao J., Radisky D. C., Knutson K. L., Kalari K. R., Yao J. Z., Baddour L. M., Chia N., Degnim A. C. The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease // Scientific Reports. Nature Publishing Group. 2016;6(1):30751. Doi: 10.1038/srep30751.Greathouse K. L., White J. R., Vargas A. J. et al. Interaction between the microbiome and TP53 in human lung cancer // Genome Biology. - 2018. - Vol. 19, № 1. - P. 1-16. Doi: 10.1186/s13059-018-1501-6.Greathouse K. L., White J. R., Vargas A. J., Bliskovsky V. V., Beck J. A., Muhlinen von N., Polley E. C., Bowman E. D., Khan M. A., Robles A. I., Cooks T., Ryan B. M., Padgett N., Dzutsev A. H., Trinchieri G., Pineda M. A., Bilke S., Meltzer P. S., Hokenstad A. N., Stickrod T. M., Walther-Antonio M. R., Earl J. P., Mell J. C., Krol J. E., Balashov S. V., Bhat A. S., Ehrlich G. D., Valm A., Deming C., Conlan S., Oh J., Segre J. A., Harris C. C. Interaction between the microbiome and TP53 in human lung cancer // Genome Biology. 2018;19(1):1-16. Doi: 10.1186/s13059-018-1501-6.Yamamura K., Baba Y., Nakagawa S. et al. Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis // Clin. Cancer Res. - 2016. - Vol. 22, № 22. - P. 5574-5581. Doi: 10.1158/1078-0432.CCR-16-1786.Yamamura K., Baba Y., Nakagawa S., Mima K., Miyake K., Nakamura K., Sawayama H., Kinoshita K., Ishimoto T., Iwatsuki M., Sakamoto Y., Yamashita Y., Yoshida N., Watanabe M., Baba H. Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis // Clin Cancer Res. 2016;22(22):5574-5581. Doi: 10.1158/1078-0432.CCR-16-1786.Deshpande N. P., Riordan S. M., Castano-Rodriguez N. et. al. Signatures within the esophageal microbiome are associated with host genetics, age, and disease. Microbiome // BioMed Central. - 2018. - Vol. 6, № 1. - P. 227. Doi: 10.1186/s40168-018-0611-4.Deshpande N. P, Riordan S. M., Castano-Rodriguez N., Wilkins M. R., Kaakoush N. O. Signatures within the esophageal microbiome are associated with host genetics, age, and disease // Microbiome. BioMed Central. 2018;6(1):227. Doi: 10.1186/s40168-018-0611-4.Baba Y., Iwatsuki M., Yoshida N. et. al. Review of the gut microbiome and esophageal cancer. - Pathogenesis and potential clinical implications // Ann. Gastroenterol. Surg. - 2017. - Vol. 1, № 2. - P. 99-104. Doi: 10.1002/ags3.12014.Baba Y., Iwatsuki M., Yoshida N., Watanabe M., Baba H. Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications // Ann Gastroenterol Surg. John Wiley & Sons, Ltd. 2017;1(2):99-104. Doi: 10.1002/ags3.12014.Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopath-ological Features of Colorectal Cancer / K. S. Viljoen, A. Dakshinamurthy, P. Goldberg, J. M.Blackburn // McDowell A, editor. PLoS ONE. - 2015. - Vol. 10, № 3. - P. e0119462-21. Doi: 10.1371/journal.pone.0119462.Viljoen K. S., Dakshinamurthy A., Goldberg P., Blackburn J. M. Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer // PLoS ONE. 2015;10(3):e0119462-21. Doi: 10.1371/journal.pone.0119462.Dejea C. M., Wick E. C., Hechenbleikner E. M. et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci USA. National Academy of Sciences. - 2014. - Vol. 111, № 51. - P. 18321-18326. Doi: 10.1073/pnas.1406199111.Dejea C. M., Wick E. C., Hechenbleikner E. M., White J. R., Mark Welch J. L., Rossetti B. J., Peterson S. N., Snesrud E. C., Borisy G. G., Lazarev M., Stein E., Vadivelu J., Roslani A. C., Malik A. A., Wanyiri J. W., Goh K. L., Thevambiga I., Fu K, Wan F., Llosa N., Housseau F., Romans K, Wu X., McAllister F. M., Wu S., Vogelstein B., Kinzler K. W., Pardoll D. M., Sears C. L. Microbiota organization is a distinct feature of proximal colorectal cancers // Proc Natl Acad Sci USA. National Academy of Sciences. 2014;111(51):18321-18326. Doi: 10.1073/pnas.1406199111.Zolfo M., Tett A., Jousson O. et al. MetaMLST: Multi-locus strain-level bacterial typing from metagenomic samples // Nucleic Acids Research. - 2017. - Vol. 45, № 2. -P. e7-e7. Doi: 10.1093/nar/gkw837.Zolfo M., Tett A., Jousson O., Donati C., Segata N. MetaMLST: multi-locus strain-level bacterial typing from metagenomic samples. Nucleic Acids Research. 2017; 45(2):e7-e7. Doi: 10.1093/nar/gkw837.Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes / T. Clavel, J. C. Gomes-Neto, I. Lagkouvardos, A. E. Ramer-Tait // Immunol Rev. - 2017. - Vol. 279, № 1. -P. 8-22. Doi: 10.1111/imr.12578.Clavel T., Gomes-Neto J. C., Lagkouvardos I., Ramer-Tait A. E. Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes // Immunol Rev. 2017;279(1):8-22. Doi: 10.1111/imr.12578.Overmann J., Abt B., Sikorski J. Present and Future of Culturing Bacteria. Annu Rev Microbiol. - 2017. -Vol.71, № 1. - P. 711-730. Doi: 10.1146/annurev-micro-090816-093449.Overmann J., Abt B., Sikorski J. Present and Future of Culturing Bacteria // Annu Rev Microbiol. 2017;71(1):711-30. Doi: 10.1146/annurev-micro-090816-093449.Tetz V., Tetz G. Draft Genome Sequence of a Strain of Bacillus intestinalissp. nov., a New Member of Sporo-biota Isolated from the Small Intestine of a Single Patient with Intestinal Cancer // Genome Announc. - 2017. - Vol. 5, № 22. - P. 14-12. Doi: 10.1128/genomeA.00489-17.Tetz V., Tetz G. Draft Genome Sequence of a Strain of Bacillus intestinalissp. nov., a New Member of Sporobiota Isolated from the Small Intestine of a Single Patient with Intestinal Cancer // Genome Announc. 2017;5(22):14-22. Doi: 10.1128/genomeA.00489-17.Tetz G., Vecherkovskaya M., Zappile P. et al. Complete Genome Sequence of Kluyvera intestinisp. nov., Isolated from the Stomach of a Patient with Gastric Cancer // Genome Announc. - 2017. - Vol. 5, № 43. - P. 1-2. Doi: 10.1128/genomeA.01184-17.Tetz G., Vecherkovskaya M., Zappile P., Dolgalev I., Tsirigos A., Heguy A., Tetz V. Complete Genome Sequence of Kluyvera intestinisp. nov., Isolated from the Stomach of a Patient with Gastric Cancer // Genome Announc. 2017;5(43):1-2. Doi: 10.1128/genomeA.01184-17.Tetz G., Tetz V., Vecherkovskaya M. Genomic characterization and assessment of the virulence and antibiotic resistance of the novel species Paenibacillus sp. strain VT-400, a potentially pathogenic bacterium in the oral cavity of patients with hematological malignancies. Gut Pathog // BioMed. Central. - 2016. - Vol. 8, № 1. - P. 1-9. Doi: 10.1186/s13099-016-0089-1.Tetz G., Tetz V., Vecherkovskaya M. Genomic characterization and assessment of the virulence and antibiotic resistance of the novel species Paenibacillus sp. strain VT-400, a potentially pathogenic bacterium in the oral cavity of patients with hematological malignancies // Gut Pathog. BioMed Central. 2016;8(1):1-9. Doi: 10.1186/s13099-016-0089-1.Vecherkovskaya M. F., Tetz G. V, Tetz V. V. Complete Genome Sequence of the Streptococcus sp. Strain VT 162, Isolated from the Saliva of Pediatric Oncohematology Patients. - 2014. - Vol. 2, № 4. Doi: 10.1128/genomeA.00647-14.Vecherkovskaya M. F., Tetz G. V., Tetz V. V. Complete Genome Sequence of the Streptococcus sp. Strain VT 162, Isolated from the Saliva of Pediatric Oncohematology Patients. 2014;2(4). Doi: 10.1128/genomeA.00647-14.Gabrilovich D. I. Myeloid-Derived Suppressor Cells. Cancer Immunol Res // American Association for Cancer Research. - 2017. - Vol. 5, № 1. - P. 3-8. Doi: 10.1158/2326-6066.CIR-16-0297.Gabrilovich D. I. Myeloid-Derived Suppressor Cells. Cancer Immunol Res. American Association for Cancer Research. 2017 (1):3-8. DOI: 10.1158/2326-6066.CIR-16-0297Arthur J. C., Perez-Chanona E., Muhlbauer M. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science // American Association for the Advancement of Science. - 2012. - Vol. 338, № 6103. - P. 120-123. Doi: 10.1126/science.1224820.Arthur J. C., Perez-Chanona E., Muhlbauer M., Tom-kovich S., Uronis J. M., Fan T.-J., Campbell B. J., Abujamel T., Dogan B., Rogers A. B., Rhodes J. M., Stintzi A., Simpson K. W., Hansen J. J., Keku T. O., Fodor A. A., Jobin C. Intestinal inflammation targets cancer-inducing activity of the microbiota // Science. American Association for the Advancement of Science. 2012;338(6103):120-123. Doi: 10.1126/science.1224820.Zackular J. P., Baxter N. T., Iverson K. D. et al. The Gut Microbiome Modulates Colon Tumorigenesis // American Society for Microbiology. - 2013. - Vol. 4, № 6. -P. e00692-13-13. Doi: 10.1128/mBio.00692-13.Zackular J. P., Baxter N. T., Iverson K. D., Sadler W. D., Petrosino J. F., Chen G. Y., Schloss P. D., Blaser M. J. The Gut Microbiome Modulates Colon Tumorigenesis // American Society for Microbiology. 2013;4(6):e00692-13-13. Doi: 10.1128/mBio.00692-13.Crawford R. W., Wangdi T., Spees A. M. et al. Loss of very-long O-antigen chains optimizes capsule-mediated immune evasion by Salmonella enterica serovar Typhi // American Society for Microbiology. - 2013. - Vol. 4, № 4. - P. 63. Doi: 10.1128/mBio.00232-13.Crawford R. W., Wangdi T., Spees A. M., Xavier M. N., Tsolis R. M., Baumler A. J. Loss of very-long O-an-tigen chains optimizes capsule-mediated immune evasion by Salmonella enterica serovar Typhi // American Society for Microbiology. 2013;4(4):63. Doi: 10.1128/mBio.00232-13.Cress B. F., Englaender J. A., He W. et al. Masquerading microbial pathogens. - capsular polysaccharides mimic host-tissue molecules // FEMS Microbiology Reviews. - 2014. - Vol. 38, № 4. - P. 660-697. Doi: 10.1111/15746976.12056.Cress B. F., Englaender J. A., He W., Kasper D., Linhardt R. J., Koffas M. A. G. Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules // FEMS Microbiology Reviews. 2014;38(4):660-697. Doi: 10.1111/1574-6976.12056.Cullen T. W., Giles D. K., Wolf L. N. et al. Helicobacter pylori versus the host. - remodeling of the bacterial outer membrane is required for survival in the gastric mucosa // PLoS Pathog. - 2011. - Vol. 7, № 12. - P. e1002454. Doi: 10.1371/journal.ppat.1002454.Cullen T. W., Giles D. K., Wolf L. N., Ecobichon C., Boneca I. G., Trent M. S. Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa // PLoS Pathog. 2011;7(12):e1002454. Doi: 10.1371/journal.ppat.1002454.Andersen-Nissen E., Smith K. D., Strobe K. L. et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proceedings of the National Academy of Sciences // National Academy of Sciences. - 2005. - Vol. 102, № 26. - P. 92479252. Doi: 10.1073/pnas.0502040102.Andersen-Nissen E., Smith K. D., Strobe K. L., Barrett S. L. R., Cookson B. T., Logan S. M., Aderem A. Evasion of Toll-like receptor 5 by flagellated bacteria // Proceedings of the National Academy of Sciences. National Academy of Sciences. 2005;102(26):9247-9252. Doi: 10.1073/pnas.0502040102.Raibaud S., Schwarz-Linek U., Kim J. H. et al. Borrelia burgdorferi binds fibronectin through a tandem beta-zipper, a common mechanism of fibronectin binding in staphylococci, streptococci, and spirochetes // J. Biol. Chem. / American Society for Biochemistry and Molecular Biology. - 2005. - Vol. 280, № 19. - P. 18803-18809. Doi: 10.1074/jbc.M501731200.Raibaud S., Schwarz-Linek U., Kim J. H., Jenkins H. T., Baines E. R., Gurusiddappa S., Hook M., Potts J. R. Borrelia burgdorferi binds fibronectin through a tandem beta-zipper, a common mechanism of fibronectin binding in staphylococci, streptococci, and spirochetes // J Biol Chem. American Society for Biochemistry and Molecular Biology. 2005;280(19):18803-18809. Doi: 10.1074/jbc.M501731200Wiedemann T., Hofbaur S., Tegtmeyer N. et al. Helicobacter pylori CagL dependent induction of gastrin expression via a novel ave5-integrin-integrin linked kinase signalling complex. Gut // BMJ Publishing Group. - 2012. - Vol. 61, №7. - P. 986-96. Doi: 10.1136/gutjnl-2011-300525.Wiedemann T., Hofbaur S., Tegtmeyer N., Huber S., Sewald N., Wessler S., Backert S., Rieder G. Helicobacter pylori CagL dependent induction of gastrin expression via a novel ave5-integrin-integrin linked kinase signalling complex. Gut. BMJ Publishing Group. 2012;61(7):986-96. Doi: 10.1136/gutjnl-2011-300525.The inflammatory microenvironment and microbiome in prostate cancer development. Nature Publishing Group / K. S. Sfanos, S. Yegnasubramanian, W. G. Nelson, A. M. De Marzo // Nature Publishing Group. - 2017. - Vol. 15, № 1. - P. 11-24. Doi: 10.1038/nrurol.2017.167.Sfanos K. S., Yegnasubramanian S., Nelson W. G., De Marzo A. M. The inflammatory microenvironment and microbiome in prostate cancer development // Nature Publishing Group. 2017;15(1):11-24. Doi: 10.1038/nrurol.2017.167.Rosadi F., Fiorentini C., Fabbri A. Bacterial protein toxins in human cancers. Frisan T, editor // Pathogens and Disease. - 2016. - Vol. 74, №1. - P. 105. Doi: 10.1093/femspd/ftv105.Rosadi F., Fiorentini C., Fabbri A. Bacterial protein toxins in human cancers // Pathogens and Disease. 2016;74(1):105. Doi: 10.1093/femspd/ftv105.Lu R., Wu S., Zhang Y.-G. et al. Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis // Nature Publishing Group. - 2014. - Vol. 3, № 6. - P. e105-5. Doi: 10.1038/oncsis.2014.20Lu R., Wu S., Zhang Y.-G., Xia Y., Liu X., Zheng Y., Chen H., Schaefer K. L., Zhou Z., Bissonnette M., Li L., Sun J. Enteric bacterial protein AvrA promotes colonic tumorigen-esis and activates colonic beta-catenin signaling pathway // Oncogenesis. Nature Publishing Group. 2014;3(6):105-105. Doi: 10.1038/oncsis.2014.20.Tetz V. V, Tetz G. V. Bacterial DNA induces the formation of heat-resistant disease-associated in human plasma // Scientific Reports. -2019. Doi: 10.1038/s41598-019-54618-9.Tetz V. V., Tetz G. V. Bacterial DNA induces the formation of heat-resistant disease-associated in human plasma. Scientific Reports. 2019;(9):17995. Doi: 10.1038/s41598-019-54618-9.Dong Q. L., Xing X. Y. Cancer cells arise from bacteria. Cancer Cell Int // BioMed. Central. - 2018. - Vol. 18, № 1. - P. 1-9. Doi: 10.1186/s12935-018-0699-4.Dong Q.-L., Xing X.-Y. Cancer cells arise from bacteria // Cancer Cell Int. BioMed Central; 2018;18(1):1-9. Doi: 10.1186/s12935-018-0699-4.Garrett W. S. Cancer and the microbiota // Science. - 2015. - Vol. 348, № 6230. - P. 80-86. Doi: 10.1126/science.aaa4972.Garrett W. S. Cancer and the microbiota // Science. 2015;348(6230):80-86. Doi: 10.1126/science.aaa4972.Microbiome and Anticancer Immunosurveillance / L. Zitvogel , M. Ayyoub, B. Routy, G. Kroemer // Cell. - 2016. - Vol. 165, № 2. - P. 276-287. Doi: 10.1016/j.cell.2016.03.001.Zitvogel L., Ayyoub M., Routy B., Kroemer G. Microbiome and Anticancer Immunosurveillance // Cell. 2016; 165(2):276-287. Doi: 10.1016/j.cell.2016.03.001.Yoshimoto S., Loo T. M, Atarashi K. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome // Nature. Nature Publishing Group. -2013. - Vol. 499, № 7456. -P. 97-101. Doi: 10.1038/nature12347.Yoshimoto S., Loo T. M., Atarashi K., Kanda H., Sato S., Oyadomari S., Iwakura Y., Oshima K., Morita H., Hattori M., Honda K., Ishikawa Y,. Hara E,. Ohtani N. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome // Nature. Nature Publishing Group. 2013;499(7456):97-101. Doi: 10.1038/nature12347.Wu S., Rhee K.-J., Zhang M. et al. Bacteroides fra-gilis toxin stimulates intestinal epithelial cell shedding and Y-secretase-dependent E-cadherin cleavage. Journal of Cell Science // The Company of Biologists Ltd. - 2007. - Vol. 120, № 11. - P. 1944-1952. Doi: 10.1242/jcs.03455.Wu S., Rhee K.-J., Zhang M., Franco A., Sears C. L. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and Y-secretase-dependent E-cadherin cleavage // Journal of Cell Science. The Company of Biologists Ltd. 2007;120(11):1944-1952. Doi: 10.1242/jcs.03455.Wang F., Meng W., Wang B. Helicobacter pylori-in-duced gastric inflammation and gastric cancer // Elsevier. - 2014. - Vol. 345, № 2. - P. 196-202. Doi: 10.3892/ol.2016.5506.Wang F., Meng W., Wang B. Helicobacter pylori-induced gastric inflammation and gastric cancer // Elsevier. 2014; 345(2):196-202. Doi: 10.3892/ol.2016.5506.Fassi Fehri L., Mak T. N., Laube B. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells // Int. J. Med. Microbiol. - 2011. - Vol. 301, № 1. - P. 69-78. Doi: 10.1016/j.ijmm.2010.08.014.Fassi Fehri L., Mak T. N., Laube B., Brinkmann V., Ogilvie L. A., Mollenkopf H., Lein M., Schmidt T., Meyer T. F., Bruggemann H. Prevalence of Propionibac-terium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells // Int J Med Microbiol. 2011;301(1):69-78. Doi: 10.1016/j.ijmm.2010.08.014.Peek R. M., Blaser M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas // Nature Reviews Cancer. - 2002. - Vol. 2, № 1. - P. 28-37. Doi: 10.1038/nrc703.Peek R. M., Blaser M. J. Helicobacter pylori and gastrointestinal tract adenocarcinomas // Nature Reviews Cancer. 2002;2(1):28-37. Doi: 10.1038/nrc703.Kawasaki K., Ernst R. K, Miller S. I. 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4 // J. Biol. Chem. American Society for Biochemistry and Molecular Biology. - 2004. - Vol. 279, № 19. - P. 20044-20048. Doi: 10.1074/jbc.M401275200.Kawasaki K., Ernst R. K., Miller S. I. 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4 // J Biol Chem. American Society for Biochemistry and Molecular Biology. 2004;279(19):20044-20048. Doi: 10.1074/jbc.M401275200.Rubinstein M. R., Wang X., Liu W. Fusobacterium nu-cleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/e-Catenin Signaling via its FadA Adhesin // Cell Host and Microbe. - 2013. - Vol. 14, № 2. - P. 195-206. Doi: 10.1016/j.chom.2013.07.012.Rubinstein M. R., Wang X., Liu W., Hao Y., Cai G., Han Y. W. Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/e-Catenin Signaling via its FadA Adhesin // Cell Host and Microbe. Cell Press. 2013;14(2):195-206. Doi: 10.1016/j.chom.2013.07.012.Wardill H. R., Gibson R. J., Van Sebille Y. Z. A. et al. Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms // Mol. Cancer Ther.American Association for Cancer Research. -2016. - Vol. 15, № 6. - P. 1376-1386. Doi: 10.1158/1535-7163.MCT-15-0990.Wardill H. R., Gibson R. J., Van Sebille Y. Z. A., Secombe K. R., Coller J. K., White I. A., Manavis J., Hutchinson M. R., Staikopoulos V., Logan R. M., Bowen J. M. Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms // Mol Cancer Ther. American Association for Cancer Research. 2016;15(6):1376-1386. Doi: 10.1158/1535-7163.MCT-15-0990.Viaud S., Saccheri F., Mignot G. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide // Science. - 2013. - Vol. 342, № 6161. -P. 971-976. Doi: 10.1126/science.1240537.Viaud S., Saccheri F., Mignot G., Yamazaki T., Daillere R., Hannani D., Enot D. P, Pfirschke C., Engblom C., Pittet M. J., Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther P-L., Eberl G., Berard M., Ecobichon C., Clermont D., Bizet C., Gaboriau-Routhiau V., Cerf-Bensussan N., Opolon P., Yessaad N., Vivier E., Ryffel B., Elson C. O., Dore J, Kroemer G., Lepage P., Boneca I. G., Ghiringhelli F., Zitvogel L. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161):971-976. Doi: 10.1126/science.1240537.Sivan A., Corrales L., Hubert N. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy // Science. - 2015. - Vol. 350, № 6264. -P. 1084-1089. Doi: 10.1126/science.aac4255.Sivan A., Corrales L., Hubert N., Williams J. B., Aquino-Michaels K., Earley Z. M., Benyamin F. W., Lei Y. M., Jabri B., Alegre M.-L., Chang E. B., Gajewski T. F. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy // Science. 2015;350(6264):1084-1089. Doi: 10.1126/science.aac4255.Voorde J. V, Sabuncuoglu S., Noppen S. et al. Nucle-oside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine // J. Biol. Chem. American Society for Biochemistry and Molecular Biology. - 2014. - Vol. 289, № 19. - P. 13054-13065. Doi: 10.1074/jbc.M114.558924.Voorde J. V, Sabuncuoglu S., Noppen S., Hofer A., Ranjbarian F., Fieuws S., Balzarini J., Liekens S. Nucleo-side-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine // J Biol Chem. American Society for Biochemistry and Molecular Biology. 2014; 289(19):13054-13065. Doi: 10.1074/jbc.M114.558924.Montassier E., Gastinne T., Vangay P. et al. Chemotherapy-driven dysbiosis in the intestinal microbiome // Aliment Pharmacol Ther. - 2015. - Vol. 42, № 5. - P. 515-528. Doi: 10.1111/apt.13302.Montassier E., Gastinne T., Vangay P., Al-Ghalith G. A., Bruley des Varannes S., Massart S., Moreau P., Potel G., La Cochetiere de M. F., Batard E., Knights D. Chemotherapy-driven dysbiosis in the intestinal microbiome // Aliment Pharmacol Ther. 2015;42(5):515-528. Doi: 10.1111/apt.13302.Daillere R., Vetizou M., Waldschmitt N. et al. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. // Immunity. - 2016. - Vol. 45, № 4. - P. 931-943. Doi: 10.1016/j.immuni.2016.09.009.Daillere R., Vetizou M., Waldschmitt N., Yamazaki T., Isnard C., Poirier-Colame V., Duong C. P.M, Flament C., Lepage P., Roberti M. P., Routy B,. Jacquelot N., Apetoh L., Becharef S., Rusakiewicz S., Langella P., Sokol H., Kroemer G., Enot D., Roux A., Eggermont A., Tartour E., Johannes L.,Woerther P.-L., Chachaty E., Soria J.-C., Golden E., Formenti S., Plebanski M., Madondo M., Rosenstiel L., Raoult D., Cattoir V., Boneca I. G., Chamaillard M., Zitvogel L. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. 2016;45(4):931-943. Doi: 10.1016/j.immuni.2016.09.009.Iida N., Dzutsev A., Stewart C. A. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science // American Association for the Advancement of Science. - 2013. - Vol. 342, № 6161. -P. 967-970. Doi: 10.1126/science.1240527.Iida N., Dzutsev A., Stewart C. A., Smith L., Bouladoux N., Weingarten R. A., Molina D. A., Salcedo R., Back T., Cramer S. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment // Science. American Association for the Advancement of Science. 2013;342(6161):967-970. Doi: 10.1126/science.1240527.Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota / M. Vetizou, J. M. Pitt, R. Daillere, P. Lepage // Science. - 2015. - Vol. 350, № 6264. - P. 10771079. Doi: 10.1126/science.aad1329.Vetizou M., Pitt J. M., Daillere R., Lepage P. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota // Science. 2015;350(6264):1077-1079. Doi: 10.1126/science.aad1329.Frank M., Hennenberg E. M, Eyking A. et al. TLR signaling modulates side effects of anticancer therapy in the small intestine // J. Immunol. American Association of Immunologists. - 2015. - Vol. 194, № 4. - P. 1983-1995. Doi: 10.4049/jimmunol.1402481.Frank M., Hennenberg E. M., Eyking A,. Runzi M,. Gerken G,. Scott P,. Parkhill J,. Walker A. W., Cario E. TLR signaling modulates side effects of anticancer therapy in the small intestine // J Immunol. American Association of Immunologists. 2015;194(4):1983-1995. Doi: 10.4049/jimmunol.1402481.Kurita A., Kado S., Matsumoto T. et al. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of в-glucuronidase activity in intestinal lumen // Cancer Chemother. Pharmacol. - 2010. - Vol. 67, № 1. - P. 201-213. Doi: 10.1007/s00280-010-1310-4.Kurita A., Kado S., Matsumoto T., Asakawa N., Kaneda N., Kato I., Uchida K., Onoue M., Yokokura T. Streptomycin alleviates irinotecan-induced delayed-on-set diarrhea in rats by a mechanism other than inhibition of в-glucuronidase activity in intestinal lumen // Cancer Chemother Pharmacol. 2010;67(1):201-213. Doi: 10.1007/s00280-010-1310-4.Dubin K., Callahan M. K., Ren B. et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis // Nat. Comms. Nature Publishing Group. - 2016. - Vol. 7, № 1. - P. 10391. Doi: 10.1038/ncomms10391.Dubin K., Callahan M. K., Ren B., Khanin R., Viale A., Ling L., No D., Gobourne A., Littmann E., Huttenhower C., Pamer E. G., Wolchok J. D. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis // Nat Comms. Nature Publishing Group. 2016;7(1):10391. Doi: 10.1038/ncomms10391.Bronckaers A., Balzarini J., Liekens S. The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection. Implications for cancer therapy // Biochem. Pharmacol. - 2008. - Vol. 76, № 2. -P. 188-197. Doi: 10.1016/j.bcp.2008.04.019.Bronckaers A., Balzarini J., Liekens S. The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy // Biochem Pharmacol. 2008;76(2):188-197. Doi: 10.1016/j.bcp.2008.04.019.Wallace B. D., Wang H., Lane K. T. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. American Association for the Advancement of Science. - 2010. - Vol. 330, № 6005. - P. 831-835. Doi: 10.1126/science.1191175.Wallace B. D., Wang H., Lane K. T., Scott J. E., Orans J., Koo J. S., Venkatesh M., Jobin C., Yeh L.-A., Mani S., Redinbo M. R. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme // Science. American Association for the Advancement of Science. 2010;330(6005):831-835. Doi: 10.1126/science.1191175.Fijlstra M., Ferdous M., Koning A. M. et al. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model // Support Care Cancer. - 2015. - Vol. 23, № 6. -P. 1513-1522. Doi: 10.1007/s00520-014-2487-6.Fijlstra M., Ferdous M., Koning A. M., Rings E. H. H. M., Harmsen H. J. M., Tissing W. J. E. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model // Support Care Cancer. 2015;23(6):1513-1522. Doi: 10.1007/s00520-014-2487-6.Villeger R., Lopes A., Veziant J. et al. Microbial markers in colorectal cancer detection and/or prognosis // WJG. - 2018. - Vol. 24, № 22. - P. 2327-2347. Doi: 10.3748/wjg.v24.i22.2327.Villeger R., Lopes A., Veziant J., Gagniere J., Barnich N., Billard E., Boucher D., Bonnet M. Microbial markers in colorectal cancer detection and/or prognosis // WJG. 2018;24(22):2327-2347. Doi: 10.3748/wjg.v24.i22.2327.Amitay E. L., Krilaviciute A. Systematic review. Gut microbiota in fecal samples and detection of colorectal neoplasms // Gut microbes. - 2018. - Vol. 9, № 4. - P. 293-307. Doi: 10.1080/19490976.2018.1445957.Amitay E. L., Krilaviciute A. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms // Gut microbes. 2018;9(4):293-307. Doi: 10. 1080/19490976.2018.1445957.Yang J., Mu X., Wang Y. et al. Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers // Front Oncol. Frontiers. - 2018. - Vol. 8. - P. 520. Doi: 10.3389/fonc.2018.00520.Yang J., Mu X., Wang Y., Zhu D., Zhang J., Liang C., Chen B., Wang J., Zhao C., Zuo Z., Heng X., Zhang C., Zhang L. Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers // Front Oncol. Frontiers. 2018;(8):520. Doi: 10.3389/fonc.2018.00520.

The authors declare that there are no conflicts of interest present.